Company:  HAEMONETICS CORP (HAE)
Form Type:  10-Q
Filing Date:  11/7/2012 
CIK:  0000313143 
Address:  400 WOOD RD 
City, State, Zip:  BRAINTREE, Massachusetts 02184 
Telephone:  (781) 848-7100 
Fiscal Year:  03/30 
Last Trade
Last Trade: 
$33.54  
Change: 
-0.06 (-0.18%)  
Trade Time: 
04:01 PM EST  
Market Cap: 
$1.74B
Description of Business
Haemonetics is a global healthcare company dedicated to providing innovative blood management solutions to our customers. Our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world. Our products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does. Blood and its components (plasma, platelets, and red cells) have many vital - and frequently life-saving - clinical applications. Plasma is used for patients with major blood loss and is manufactured into pharmaceuticals to treat a variety of illnesses and hereditary disorders such as hemophilia.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I
      FINANCIAL STATEMENTS
        INCOME STATEMENT
        BALANCE SHEET
        CASH FLOW
        NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
          INCOME STATEMENT
          BALANCE SHEET
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      FINANCIAL STATEMENTS
        CASH FLOW
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      Item 1. Legal Proceedings
      Item 1A. Risk Factors
      Item 3. Defaults upon Senior Securities
      Item 6. Exhibits
    SIGNATURES
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    Certification Pursuant To
  EXHIBIT 32.2
    Certification Pursuant To
BROKERAGE PARTNERS